Invention Grant
- Patent Title: Pharmaceutical compositions
-
Application No.: US15906414Application Date: 2018-02-27
-
Publication No.: US10596120B2Publication Date: 2020-03-24
- Inventor: Masanori Ito , Kenji Egusa , Roman Messerschmid , Peter Schneider
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Edouard G. Lebel
- Priority: EP11157240 20110307; EP11158358 20110315
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/24 ; A61K9/20 ; A61K9/28 ; A61K31/155 ; A61K45/06 ; A61K31/7048 ; A61K31/522
Abstract:
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
Public/Granted literature
- US10398654B2 Pharmaceutical compositions Public/Granted day:2019-09-03
Information query
